Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liangfu Chen

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Science of the Total Environment|January 6, 2022
Near-real-time estimation of hourly open biomass burning emissions in China using multiple satellite retrievalsYuanqian Xu, Zhijiong Huang, Jiamin Ou, et al.
The Science of the Total Environment|May 28, 2023
Evaluation and uncertainty analysis of Himawari-8 hourly aerosol product version 3.1 and its influence on surface solar radiation before and during the COVID-19 outbreakChenqian Tang, Chong Shi, Husi Letu, et al.
Chemico-Biological Interactions|October 26, 2010
An integrated reactive metabolite evaluation approach to assess and reduce safety risk during drug discovery and developmentMelinda Reese, Melanie Sakatis, Jeffrey Ambroso, et al.
Journal of Biochemical and Molecular Toxicology|April 15, 2006
Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytesRichard A Graham, Lindsey O Tyler, Wojciech L Krol, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 19, 2011
Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cellsMitchell E Taub, Kirsten Mease, Rucha S Sane, et al.
Clinical Pharmacology in Drug Development|October 29, 2021
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability DeterminationKelly M Mahar, Stephen Caltabiano, Susan Andrews, et al.
Genome Research|September 8, 2012
Dynamic landscape of tandem 3' UTRs during zebrafish developmentYuxin Li, Yu Sun, Yonggui Fu, et al.
Toxicologic Pathology|October 24, 2019
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase InhibitorDavid F Adams, Mark S Watkins, Luc Durette, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 28, 2016
The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional ArchitectureLingzhong Fan, Hai Li, Junjie Zhuo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 30, 2014
Investigation of metabolism and disposition of GSK1322322, a peptidase deformylase inhibitor, in healthy humans using the entero-test for biliary samplingDonna Mamaril-Fishman, John Zhu, Min Lin, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Science of the Total Environment|January 6, 2022
Near-real-time estimation of hourly open biomass burning emissions in China using multiple satellite retrievalsYuanqian Xu, Zhijiong Huang, Jiamin Ou, et al.
The Science of the Total Environment|May 28, 2023
Evaluation and uncertainty analysis of Himawari-8 hourly aerosol product version 3.1 and its influence on surface solar radiation before and during the COVID-19 outbreakChenqian Tang, Chong Shi, Husi Letu, et al.
Chemico-Biological Interactions|October 26, 2010
An integrated reactive metabolite evaluation approach to assess and reduce safety risk during drug discovery and developmentMelinda Reese, Melanie Sakatis, Jeffrey Ambroso, et al.
Journal of Biochemical and Molecular Toxicology|April 15, 2006
Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytesRichard A Graham, Lindsey O Tyler, Wojciech L Krol, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 19, 2011
Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cellsMitchell E Taub, Kirsten Mease, Rucha S Sane, et al.
Clinical Pharmacology in Drug Development|October 29, 2021
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability DeterminationKelly M Mahar, Stephen Caltabiano, Susan Andrews, et al.
Genome Research|September 8, 2012
Dynamic landscape of tandem 3' UTRs during zebrafish developmentYuxin Li, Yu Sun, Yonggui Fu, et al.
Toxicologic Pathology|October 24, 2019
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase InhibitorDavid F Adams, Mark S Watkins, Luc Durette, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 28, 2016
The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional ArchitectureLingzhong Fan, Hai Li, Junjie Zhuo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 30, 2014
Investigation of metabolism and disposition of GSK1322322, a peptidase deformylase inhibitor, in healthy humans using the entero-test for biliary samplingDonna Mamaril-Fishman, John Zhu, Min Lin, et al.
Pageof 6